Login
Contact Us
Insights
By Topic
Dividend Stocks
Growth Stocks
Blue Chip Stocks
Market Trends
Economic Updates
Interest Rates & Inflation
Global Markets
Small Caps & Emerging Stocks
Retirement & Superannuation
By Sector
Energy
Materials
Financials including Banking
Healthcare
Industrials
Information Technology
Consumer Discretionary
Consumer Staples
Utilities
Real Estate
Market Updates
Market Wrap
Latest ASX News
Top Stocks
CBA
NAB
ANZ
WBC
CSL
BHP
Education
Learn to Invest
Stocks
Bonds
ETFs
How to Invest
What Is Investing?
What Is Diversification?
Long-Term vs Short-Term
Best Investing Strategies
Learning Centre
Fundamental Analysis
General Trading Information
Chart Patterns
Economic Indicators
Hedging
SMSF
Strategy Centre
Technical Analysis
Types of Shares
Growth Shares
Dividend Shares
Defensive Shares
ASX Listings
Companies
ETFs
SMSF
Retirement Planning Guide
Why to start investing now
Free Report
Services
Free Report
CALL 1300 720 292
Login
Contact Us
Healthcare
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Star Combo Pharma Ltd.
asx-s66
Healthcare
asx-s66
S66
AU$19.58M
19575400
Pharmaceuticals: Other
Noxopharm Ltd.
asx-nox
Healthcare
AUD
www.noxopharm.com
asx-nox
NOX
AU$19.00M
18995466
Noxopharm Ltd. engages in the research and development of drugs. It focuses on sensitizing cancer cells to radiotherapy and chemotherapy. The company was founded by Graham Kelly on October 27, 2015 and is headquartered in Chatswood, Australia.
Pharmaceuticals: Major
Rhythm Biosciences Limited
asx-rhy
Healthcare
AUD
www.rhythmbio.com
asx-rhy
RHY
AU$18.00M
18000499
Rhythm Biosciences Ltd. engages in the research, development, and commercialization of medical diagnostics technologies. It offers a diagnostic blood test for screening for colorectal cancer under the ColoSTAT brand. The company was founded on June 1, 2017, and is headquartered in Parkville, Australia.
Medical Specialties
Neurotech International Ltd.
asx-nti
Healthcare
AUD
www.neurotechinternational.com
asx-nti
NTI
AU$17.84M
17843572
Neurotech International Ltd. engages in the research, design, development, and manufacture of medical devices and solutions in Australia. Its product includes Mente Autism for the diagnosis and treatment of autism. The company was founded on January 15, 2016 and is headquartered in Nedlands, Australia.
Medical Specialties
Next Science Ltd
asx-nxs
Healthcare
USD
www.nextscience.com
asx-nxs
NXS
Buy
AU$17.53M
17529613
Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. It operates through the North America, Australia and New Zealand geographical segments. The company was founded by Matthew Myntti on October 20, 2017 and is headquartered in Sydney, Australia.
Biotechnology
Holista Colltech Limited
asx-hct
Healthcare
AUD
asx-hct
HCT
AU$16.86M
16860237
Holista CollTech Ltd. engages in the research and development, manufacture, and marketing of natural ingredients and wellness products. It operates through the following segments: Ovine Collagen, Infection Control, Dietary Supplements, and Food Ingredients. The company was founded by Rajen Manicka on September 18, 2000 and is headquartered in Perth, Australia.
Biotechnology
Immuron Limited
asx-imc
Healthcare
AUD
asx-imc
IMC
Buy
AU$15.91M
15909214
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum. This technology can be used to target viruses or bacteria and neutralize the toxins they produce on mucosal surfaces. It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment includes projects performed in Australia and United States. The Hyperimmune Products segment is composed of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994, and is headquartered in Carlton, Australia.
Pharmaceuticals: Major
Avecho Biotechnology Limited
asx-ave
Healthcare
AUD
www.phosphagenics.com
asx-ave
AVE
AU$14.28M
14280587
Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. It operates through the Production and Human Health segments. The Production segment focuses on manufacturing and sale of TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Human Health segment consists of delivery of pharmaceutical products through gels, injectables and patches including conduct of research and development activities. The company was founded by Mark Gregory Kerr on June 19, 1992 and is headquartered in Clayton, Australia.
Pharmaceuticals: Major
Terragen Holdings Ltd
asx-tgh
Healthcare
asx-tgh
TGH
AU$13.66M
13656000
Biotechnology
Memphasys Ltd
asx-mem
Healthcare
asx-mem
MEM
AU$13.01M
13007200
Biotechnology
Atomo Diagnostics Ltd.
asx-at1
Healthcare
AUD
www.atomodiagnostics.com
asx-at1
AT1
AU$12.01M
12007311
Atomo Diagnostics Ltd. engages in manufacture, research, development, and design of in-vitro medical devices for blood-based rapid diagnostic testing (RDT) for professional use and self-testing. It offers its products through the AtomoRapid range of RDT platforms. The company was founded by John Kelly in 2010 and is headquartered in Leichhardt, Australia.
Medical Specialties
TruScreen Group Ltd.
asx-tru
Healthcare
asx-tru
TRU
AU$11.76M
11760700
Medical Specialties
Firebrick Pharma Limited
asx-fre
Healthcare
asx-fre
FRE
AU$10.96M
10957300
Pharmaceuticals: Major
Percheron Therapeutics Limited
asx-per
Healthcare
AUD
www.antisense.com.au
asx-per
PER
Hold/Neutral
AU$10.87M
10874376
Percheron Therapeutics Ltd. engages in the research and development of novel antisense pharmacceuticals. It operates through the ATL1102, and ATL1103 segments. The ATL1102 segment represents the second generation antisense inhibitor of CD49d, the alpha subunit of very late antigen-four. The ATL1103 segment refers to atesidorsen is an antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin. The company was founded on November 13, 2000 and is headquartered in Toorak, Australia.
Pharmaceuticals: Major
Zoono Group Limited
asx-zno
Healthcare
NZD
http
asx-zno
ZNO
AU$10.66M
10663014
Zoono Group Ltd. is a pharmaceutical and biotechnology company. It involves in the development, manufacture, and sale of antimicrobial technology effective against all pathogens including bacteria, viruses, mould, algae, and fungi. Its products include aerosol-based sprays, surface sanitizers, treatment of acne, and mould remediation. The company was founded on October 8, 1986 and is headquartered in Auckland, New Zealand.
Pharmaceuticals: Major
OncoSil Medical Ltd
asx-osl
Healthcare
AUD
www.oncosil.com.au
asx-osl
OSL
AU$10.60M
10595139
OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. It engages in the development of novel and safer radiation therapy treatments. The company was founded by David McAuliffe on April 14, 2005 and is headquartered in North Sydney, Australia.
Medical Specialties
Tissue Repair Ltd
asx-trp
Healthcare
AUD
asx-trp
TRP
AU$10.28M
10279024
Tissue Repair Ltd. is a clinical stage bio pharmaceutical company, which develops advanced wound healing products targeting applications in the chronic wound and aesthetic procedure aftercare markets, with the potential for further development of related technologies. The company has developed an ingredient that is designed for wound healing and the biologically active pharmaceutical ingredient behaves like a decoy cell that simulates a yeast infection, resulting in the stimulation of the body's own wound repair pathways. The company was founded by Tony Charara in 2012 and is headquartered in Sydney, Australia.
Pharmaceuticals: Major
Invion Ltd.
asx-ivx
Healthcare
AUD
www.inviongroup.com
asx-ivx
IVX
AU$10.17M
10167438
Invion Ltd. is a clinical-stage life sciences company, which engages in the research and development of treatment for cancers, atherosclerosis, and infectious diseases. The company was founded on October 11, 2000 and is headquartered in Melbourne, Australia.
Pharmaceuticals: Major
Universal Biosensors, Inc. Shs Chess Depository Interests US Prohibited repr 1 sh
asx-ubi
Healthcare
USD
www.universalbiosensors.com
asx-ubi
UBI
AU$10.13M
10134294
Universal Biosensors, Inc. engages in the research, development and manufacture of medical diagnostics test systems for point-of-care professional and home use. Its products include blood glucose monitoring, coagulation testing, immunoassay, and molecular diagnostics. The company was founded in 2001 and is headquartered in Rowville, Australia.
Medical Specialties
Algorae Pharmaceuticals Limited
asx-1ai
Healthcare
AUD
www.lctglobal.com
asx-1ai
1AI
AU$10.12M
10124369
Algorae Pharmaceuticals Ltd. operates as an artificial intelligence enabled drug discovery and development company. It engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company was founded by Robert Bartlett Elliot and David Collinson in 1987 and is headquartered in Mount Eden, New Zealand.
Pharmaceuticals: Other
Calmer Co International Limited
asx-cco
Healthcare
AUD
www.fijikava.com
asx-cco
CCO
AU$9.03M
9034060
The Calmer Co International Ltd. is a biotechnology company, which engages in selling kava extracts. It operates through the following segments: Fiji Kava Trading, SPE Fiji, Fiji Kava USA, and Danodan. The company was founded on May 8, 2014, and is headquartered in Subiaco, Australia.
Pharmaceuticals: Major
Previous
Load more
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
Contact Us